Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

ELUT

+ Watchlist+ Portfolio

Elutia, Inc.

Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.85
52-Week Range
$0.50 – $1.39
Market Cap
$36.85M
P/E (TTM)
—
EPS (TTM)
-0.68
Dividend Yield
0.00%
Advanced Metrics
Price/Book
2.40
PEG Ratio
—
Return on Equity
—
Return on Assets
-36.45%
Gross Margin
57.71%
Operating Margin
-166.49%
Profit Margin
400.17%
Current Ratio
2.63
Debt/Equity
0.85
Total Debt
$12.98M
Free Cash Flow
$-32.21M
Revenue Growth
20.40%
Earnings Growth
—
Enterprise Value
$20.74M

Market Snapshot

About

Elutia Inc. is a commercial-stage company focused on developing and commercializing regenerative medicine products. The company's technology platform is based on extracellular matrix biomaterials that support tissue repair and regeneration. Elutia markets products for surgical applications including hernia repair, soft tissue reconstruction, and wound care. The company's portfolio includes both resorbable and non-resorbable biomaterial solutions designed to integrate with the body's natural healing processes.